BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 21940317)

  • 1. The prognostic role of apoptosis mediators in rectal adenocarcinoma.
    Seicean R; Crisan D; Boers JE; Mocan T; Seicean A; Funariu G; Ciuce C
    Hepatogastroenterology; 2011; 58(110-111):1490-4. PubMed ID: 21940317
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The use of molecular markers as a method to predict the response to neoadjuvant therapy for advanced stage rectal adenocarcinoma.
    Edden Y; Wexner SD; Berho M
    Colorectal Dis; 2012 May; 14(5):555-61. PubMed ID: 21689364
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of p53, p21 and cyclin D1 in penile cancer: p53 predicts poor prognosis.
    Gunia S; Kakies C; Erbersdobler A; Hakenberg OW; Koch S; May M
    J Clin Pathol; 2012 Mar; 65(3):232-6. PubMed ID: 22135025
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cyclin D1 and bax influence the prognosis after pancreatoduodenectomy for periampullary adenocarcinoma.
    Tomazic A; Pegan V; Ferlan-Marolt K; Pleskovic A; Luzar B
    Hepatogastroenterology; 2004; 51(60):1832-7. PubMed ID: 15532837
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Value of expression of p21WAF1/CIP1 as a prognostic factor in advanced middle and lower rectal cancer patients treated with preoperative radio-chemotherapy.
    Sogawa N; Takiguchi N; Koda K; Oda K; Satomi D; Kato K; Ishikura H; Miyazaki M
    Int J Oncol; 2002 Oct; 21(4):787-93. PubMed ID: 12239617
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic and predictive value of baseline and posttreatment molecular marker expression in locally advanced rectal cancer treated with neoadjuvant chemoradiotherapy.
    Bertolini F; Bengala C; Losi L; Pagano M; Iachetta F; Dealis C; Jovic G; Depenni R; Zironi S; Falchi AM; Luppi G; Conte PF
    Int J Radiat Oncol Biol Phys; 2007 Aug; 68(5):1455-61. PubMed ID: 17445998
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Apoptotic proteins as prognostic markers and indicators of radiochemosensitivity in stage II/III rectal cancers.
    Fucini C; Messerini L; Saieva C; Orzalesi L; Carroni V; Bartolini N
    Colorectal Dis; 2012 Feb; 14(2):e64-71. PubMed ID: 21848899
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic implications of cell cycle-related proteins in primary resectable pathologic N2 nonsmall cell lung cancer.
    Mohamed S; Yasufuku K; Hiroshima K; Nakajima T; Yoshida S; Suzuki M; Sekine Y; Shibuya K; Iizasa T; Farouk A; Fujisawa T
    Cancer; 2007 Jun; 109(12):2506-14. PubMed ID: 17487846
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Expression and significance of cell cycle regulators in gastric carcinoma].
    Wu JF; Shao JC; Wang DB; Qin R; Zhang H
    Ai Zheng; 2005 Feb; 24(2):175-9. PubMed ID: 15694028
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Elevated p21 expression is associated with poor prognosis of rectal stromal tumors after resection.
    Hu TH; Tai MH; Chuah SK; Chen HH; Lin JW; Huang HY; Chou YP; Yi LN; Kuo CM; Changchien CS
    J Surg Oncol; 2008 Aug; 98(2):117-23. PubMed ID: 18521824
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative analysis of prognostic significance of molecular markers of apoptosis with clinical stage and tumor differentiation in patients with colorectal cancer: a single institute experience.
    Ivanov K; Kolev N; Tonev A; Nikolova G; Krasnaliev I; Softova E; Tonchev A
    Hepatogastroenterology; 2009; 56(89):94-8. PubMed ID: 19453036
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of the prognostic value of a panel of tissue tumor markers and established clinicopathological factors in patients with gastric cancer.
    Wiksten JP; Lundin J; Nordling S; Kokkola A; Haglund C
    Anticancer Res; 2008; 28(4C):2279-87. PubMed ID: 18751407
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The overexpression of c-met as a prognostic indicator for gastric carcinoma compared to p53 and p21 nuclear accumulation.
    Drebber U; Baldus SE; Nolden B; Grass G; Bollschweiler E; Dienes HP; Hölscher AH; Mönig SP
    Oncol Rep; 2008 Jun; 19(6):1477-83. PubMed ID: 18497953
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bcl-2, bax and p53 expression in rectal adenocarcinoma. Correlation with classic pathologic prognostic factors and patients' outcome.
    Tsamandas AC; Kardamakis D; Petsas T; Zolota V; Vassiliou V; Matatsoris T; Kalofonos H; Vagianos CE; Scopa CD
    In Vivo; 2007; 21(1):113-8. PubMed ID: 17354623
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dynamic expression profile of p21WAF1/CIP1 and Ki-67 predicts survival in rectal carcinoma treated with preoperative radiochemotherapy.
    Rau B; Sturm I; Lage H; Berger S; Schneider U; Hauptmann S; Wust P; Riess H; Schlag PM; Dörken B; Daniel PT
    J Clin Oncol; 2003 Sep; 21(18):3391-401. PubMed ID: 12885834
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression and clinical significance of cell cycle regulatory proteins in gallbladder and extrahepatic bile duct cancer.
    Kim WB; Han HJ; Lee HJ; Park SS; Song TJ; Kim HK; Suh SO; Kim YC; Choi SY
    Ann Surg Oncol; 2009 Jan; 16(1):23-34. PubMed ID: 18979138
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunohistochemical study of cell cycle-associated proteins in adenocarcinoma of the uterine cervix treated with radiotherapy alone: P53 status has a strong impact on prognosis.
    Suzuki Y; Nakano T; Kato S; Ohno T; Tsujii H; Oka K
    Int J Radiat Oncol Biol Phys; 2004 Sep; 60(1):231-6. PubMed ID: 15337561
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of CD24, p21, p53, and c-myc in alpha-fetoprotein-producing gastric cancer: Correlation with clinicopathologic characteristics and survival.
    Liu X; Yu H; Cai H; Wang Y
    J Surg Oncol; 2014 Jun; 109(8):859-64. PubMed ID: 24619835
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor necrosis is a new promising prognostic factor in colorectal cancer.
    Pollheimer MJ; Kornprat P; Lindtner RA; Harbaum L; Schlemmer A; Rehak P; Langner C
    Hum Pathol; 2010 Dec; 41(12):1749-57. PubMed ID: 20869096
    [TBL] [Abstract][Full Text] [Related]  

  • 20. p53 and p21 Expression levels predict organ preservation and survival in invasive bladder carcinoma treated with a combined-modality approach.
    Garcia del Muro X; Condom E; Vigués F; Castellsagué X; Figueras A; Muñoz J; Solá J; Soler T; Capellà G; Germà JR
    Cancer; 2004 May; 100(9):1859-67. PubMed ID: 15112266
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.